SP PHARMA CONSULTING LIMITED

Company number 07833802 ·

Active

Net assets, total assets & total liabilities 2015 – 2024

  • Total assets
  • Net assets
  • Total liabilities
-£200k £0 £200k £400k £600k £800k 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Total assets 2015: £239,631 Total assets 2016: £281,316 Total assets 2017: £365,573 Total assets 2018: £406,777 Total assets 2019: £412,085 Total assets 2020: £492,026 Total assets 2021: £552,034 Total assets 2022: £686,031 Total assets 2023: £632,825 Total assets 2024: £567,340 Total assets Net assets 2015: £162,410 Net assets 2020: £386,775 Net assets 2021: £478,135 Net assets 2022: £596,424 Net assets 2023: £573,665 Net assets 2024: £564,896 Net assets Total liabilities 2015: -£77,221 Total liabilities 2016: -£89,393 Total liabilities 2017: -£97,535 Total liabilities 2018: -£83,077 Total liabilities 2019: -£76,192 Total liabilities 2020: -£105,615 Total liabilities 2021: -£106,711 Total liabilities 2022: -£119,145 Total liabilities 2023: -£59,160 Total liabilities 2024: -£2,444 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2023 – 2024

0 0 0 0 0 1 2023 2024 2023: 1 2024: 0

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 13 years

Latest accounts (2024-12-31): Audit exempt (accountant's report).

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2024-12-31 £567,340 -£2,444 £564,896 £566,763 0
2023-12-31 £632,825 -£59,160 £573,665 £632,825 1
2022-12-31 £686,031 -£119,145 £596,424 £651,242
2021-11-30 £552,034 -£106,711 £478,135 £532,034
2020-11-30 £492,026 -£105,615 £386,775 £448,826
2019-11-30 £412,085 -£76,192 £397,787
2018-11-30 £406,777 -£83,077 £405,907
2017-11-30 £365,573 -£97,535 £360,458
2016-11-30 £281,316 -£89,393 £262,117
2015-11-30 £239,631 -£77,221 £162,410 £214,089
2014-11-30 £195,014 -£54,598 £140,416 £163,005
2013-11-30 £214,853 -£106,306 £108,547 £82,077
2012-11-30 £85,245 -£29,241 £56,004 £49,276

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.